Use of fibrin glue (beriplast) in the management of @entity548 XXXX .

@entity1 @entity2002 @entity556 @entity101 @entity548 @entity2312
BACKGROUND AND AIMS: Gastric @entity548 is a serious complication of portal @entity101 . The optimum endoscopic treatment of @entity548 @entity2312 is yet to be defined. We evaluated the use of Beriplast, which is a solution of @entity2002 and @entity556 , in controlling @entity2312 . @entity1 AND METHODS: Fifteen @entity1 presenting with @entity2312 were entered into an open trial of endoscopic gastric intravariceal injection treatment with Beriplast (fibrin sealant) and followed for up to 1 month after endoscopic treatment. RESULTS: There was failure to control @entity548 in one @entity1 . Four @entity1 had rebleeding after the index bleed. All four were reinjected with Beriplast, and the @entity548 was controlled in three. All @entity1 were followed for 30 days, and the 30-day mortality following injection treatment was one. Fourteen @entity1 were discharged from the hospital after the first episode of @entity2312 . None of the @entity1 had injection-induced complications. CONCLUSIONS: These results show that Beriplast is a safe and simple endoscopic treatment option and is very effective in controlling @entity2312 .
